Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating urinary system stone and inflammation

A composition and drug technology, applied in the directions of drug combinations, urinary system diseases, pharmaceutical formulations, etc., can solve the problems of high recurrence rate, difficult to treat urinary system inflammation, etc., and achieve the effects of short course of treatment, significant stone removal effect, and difficult recurrence.

Inactive Publication Date: 2006-10-25
陈贤柱
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Inflammation of the urinary system is difficult to treat and has a high recurrence rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] The components and parts by weight of the components included in the formulation of the pharmaceutical composition used in the present embodiment are as follows:

[0040] Money grass 30;  storage 15; Mutong 6; Alisma 10;

[0041] psyllium 12; mallow seeds 10; dandelion 30; Qumai 10;

[0042] Talc 30; Haijinsha 12; Liu Jinu 12; Amber 12;

[0043] Achyranthes bidentata 15; Frankincense 10; Gallinaceae 12; Dung beetle 6;

[0044] Wang Buliuxing 12; Turtle Armor 15.

[0045] The medicinal materials are weighed according to the parts by weight of each component in the formula, ground and pulverized, mixed, prepared into a powder by a conventional method of traditional Chinese medicine preparation, and packed in small portions, each 3 grams.

[0046] Clinical patient statistics: 60 patients were treated with the powder medicine provided in this embodiment, and all patients were diagnosed by the hospital. Among them, there were 18 cases of kidney stones, 12 cases of urete...

Embodiment 2

[0051] The components and parts by weight of each component included in the formulation of the pharmaceutical composition used in the present embodiment are as follows:

[0052] Money grass 27;  storage 12; Mutong 3; Alisma 10;

[0053] psyllium seed 9; mallow seed 7; dandelion 27; Qumai 10;

[0054] Talc 27; Haijinsha 9; Liu Jinu 9; Amber 9;

[0055] Achyranthes bidentata 12; Frankincense 13; Gallus gallus 10; Dung beetle 5;

[0056] Wang Buliu Xing 10; Turtle Armor 12. .

[0057] The medicinal materials are weighed according to the parts by weight of each component in the formula, ground and pulverized, mixed, and prepared into capsules by conventional methods of pharmaceutical preparations, each 3 grams.

[0058] Clinical patient statistics: 51 patients were treated with the powder medicine provided in this embodiment, and all patients were diagnosed by the hospital. Among them, there were 11 cases of kidney stones, 13 cases of ureteral stones, 10 cases of bladder sto...

Embodiment 3

[0063] The components and the parts by weight of each component included in the formula of the Chinese medicine composition adopted in the present embodiment are as follows:

[0064]Money grass 33;  storage 15; Akebia 7; Alisma 7;

[0065] Plantago seed 12; mallow seed 13; dandelion 30; fenugreek 7;

[0066] Talc 33; Haijinsha 12; Liu Jinu 15; Amber 10;

[0067] Achyranthes bidentata 15; Frankincense 12; Gallinaceae 15; Dung beetle 9;

[0068] Wang Buliuxing 9; Turtle Armor 15.

[0069] The medicinal materials are weighed according to the parts by weight of each component in the formula, ground and pulverized, mixed, and prepared into pills by the conventional method of traditional Chinese medicine preparation, each pill is 3 grams.

[0070] Clinical patient statistics: 52 patients were treated with the powder medicine provided in this embodiment, and all patients were diagnosed by the hospital. Among them, there were 12 cases of kidney stones, 12 cases of ureteral stones...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a Chinese medicine composition for effectively curing lithiasis of urinary system and inflammation of urinary system. Said Chinese medicine composition includes, 8 Chinese medicinal materials of moneywort, knotgrass, mutong stem, alisma tuber, plantago seed, mallow seed and others. Its cure rate is high.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating urinary calculus and urinary system inflammation. Background technique [0002] Calculus disease is a common and frequently-occurring disease, and its causes mainly include factors such as region, water and soil, living and eating habits, and personal constitution. The incidence of calculi disease is increasing year by year, and gallstones and urinary calculi are more common clinically. Gallstones generally manifest as upper abdominal pain, fullness, loss of appetite, hiccups, right back soreness, and worse, chills and fever, nausea and vomiting, jaundice, etc.; urinary system stones manifest as waist pain, colic in the kidney area , dysuria, urgency, hematuria, dysuria, etc. If the treatment is not timely, severe cases can lead to insufficiency of liver, kidney and other organs, which is life-threatening. [0003] The treatment method o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/884A61K9/14A61K9/20A61K9/48A61K35/57A61P13/02A61P13/04A61P13/08A61P13/10
Inventor 陈贤柱陈光鹏
Owner 陈贤柱
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com